Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING LLC
GLOBETECH MEDIA
GLOBETECH PUBLISHING LLC

Novel Technique Improves Investigation of Interactions Between HIV and Malaria Parasite

By BiotechDaily International staff writers
Posted on 27 Aug 2012
A new video article describes a novel technique used to study the interactions between HIV-1 and Plasmodium falciparum in cultured human cells, allowing scientists to explore different parameters of coinfection by the two microbes.

Due to their extensive overlap in some developing regions, especially Sub-Saharan Africa, coinfections with malaria and HIV-1 are common, but the interplay between the two diseases is poorly understood and a systematic analysis of the interactions in different relevant human primary cell populations is critically needed. Each disease affects the immune system differently and by studying coinfection at different phases of each disease in vitro, scientists can better understand how different stages of malaria infection and HIV reproduction affect the onset and severity of the other disease.

In this study, an in vitro Plasmodium-HIV-1 coinfection model was developed and used to investigate the impact of P. falciparum-infected red blood cells on the HIV-1 replicative cycle in human primary monocyte-derived macrophages (MDMs). The impact of parasite exposure on HIV-1 transcriptional/translational events was monitored by using single cycle pseudotyped viruses in which a luciferase reporter gene has replaced the Env gene, while the effect on the quantity of progeny virus released by the infected macrophages is determined by measuring the HIV-1 capsid protein p24 by ELISA in cell supernatants. The researchers observed that exposure of P. falciparum to MDMs, decreases their susceptibility to HIV-1 infection, exerting a clear detrimental effect on the HIV-1 replicative cycle in macrophages (not excluding the possibility of other effects under different conditions).

The new technique, developed and applied by the laboratory led by Dr. David Richard of the Centre Hospitalier Universitaire de Quebec (CHUQ; Quebec City, Quebec, CA; www.chuq.qc.ca), was published August 15, 2012, in the online video Journal of Visualized Experiments (JoVE). "By publishing in JoVE, you really see what is happening in the experiment. The visual representation helps succinctly explain a long procedure, and gives you a fuller picture of the schematic complexity," said Dr. Richards. He hopes that this publication will give the scientific community an important additional tool to look at the interactions of the coinfection encounter on a cellular level and to more thoroughly dissect these interactions in a simplified system. This versatile system can also be adapted to monitor other factors and to use other primary cell types susceptible to HIV-1 infection. "Publication of the protocol in JoVE will allow researchers around the world to see a detailed demonstration of this system, which will help bring the technology to their laboratories," said JoVE editor Dr. Charlotte Frank Sage.

Related Links:

Centre Hospitalier Universitaire de Quebec
Journal of Visualized Experiments




Channels

Genomics/Proteomics

view channel
Image: Cancer cells, left, were pretreated with a drug that blocks the ERK signal, and right, without the pretreatment. Top cells are untreated, while the bottom ones are stimulated (Photo courtesy of the Weizmann Institute of Science).

Prevention of ERK Nuclear Translocation Blocks Cancer Proliferation in Animal Models

A team of cell biologists has shown that the cancer promoting effects of ERK dysregulation can be blocked by low molecular weight drugs that prevent translocation of this kinase from the cells' cytoplasm... Read more

Drug Discovery

view channel
Image: Star-like glial cells in red surround alpha-beta plaques in the cortex of a mouse with a model of Alzheimer\'s disease (Photo courtesy of Strittmatter laboratory/Yale University).

Experimental Cancer Drug Reverses Symptoms in Mouse Model of Alzheimer's Disease

An experimental, but clinically disappointing drug for treatment of cancer has been found to be extremely effective in reversing the symptoms of Alzheimer's disease (AD) in a mouse model.... Read more

Biochemistry

view channel
Image:  Model depiction of a novel cellular mechanism by which regulation of cryptochromes Cry1 and Cry2 enables coordination of a protective transcriptional response to DNA damage caused by genotoxic stress (Photo courtesy of the journal eLife, March 2015, Papp SJ, Huber AL, et al.).

Two Proteins Critical for Circadian Cycles Protect Cells from Mutations

Scientists have discovered that two proteins critical for maintaining healthy day-night cycles also have an unexpected role in DNA repair and protecting cells against genetic mutations that could lead... Read more

Business

view channel

NanoString and MD Anderson Collaborate on Development of Novel Multi-Omic Expression Profiling Assays for Cancer

The University of Texas MD Anderson Cancer Center (Houston, TX, USA) and NanoString Technologies, Inc. (Seattle, WA, USA) will partner on development of a revolutionary new type of assay—simultaneously profiling gene and protein expression, initially aiming to discover and validate biomarker signatures for immuno-oncology... Read more
 

Events

21 Apr 2015 - 23 Apr 2015
21 Apr 2015 - 23 Apr 2015
Copyright © 2000-2015 Globetech Media. All rights reserved.